Modality of tumor endothelial VEGFR2 silencing-mediated improvement in intratumoral distribution of lipid nanoparticles-Reference-Cited by-同舟云学术

Modality of tumor endothelial VEGFR2 silencing-mediated improvement in intratumoral distribution of lipid nanoparticles

Published:2017-04 Issue: Volume:251 Page:1-10
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Yamamoto Shoshiro,Kato Akari,Sakurai Yu^ORCID,Hada Tomoya,Harashima Hideyoshi^ORCID

Funder

MHLW

AMED

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference64 articles.

1. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs;Matsumura;Cancer Res.,1986

2. Challenges and strategies in anti-cancer nanomedicine development: an industry perspective;Hare;Adv. Drug Deliv. Rev.,2017

3. Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis;Riabov;Front. Physiol.,2014

4. Cancer-associated fibroblasts: their characteristics and their roles in tumor growth;Shiga;Cancers (Basel),2015

5. Anticancer nanomedicine and tumor vascular permeability; where is the missing link?;Taurin;J. Control. Release,2012

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted delivery of nanomedicines to glioblastoma: Overcoming the clinical barrier;Journal of Drug Delivery Science and Technology;2024-09

2. Advances in delivery systems for CRISPR/Cas-mediated cancer treatment: a focus on viral vectors and extracellular vesicles;Frontiers in Immunology;2024-08-30

3. Promising future: a review of clinical applications of biopolymers in renal cell carcinoma;Journal of Cancer Metastasis and Treatment;2024-04-18

4. Modulation of the Tumor Stroma and Associated Novel Nanoparticle Strategies to Enhance Tumor Targeting;Surgeries;2024-02-12

5. Theranostic Lipid Nanoparticles for Renal Cell Carcinoma;Advanced Materials;2023-12-03